Skip to main content
. 2021 Sep 20;21:977. doi: 10.1186/s12879-021-06709-0

Table 3.

Resistance rates of 113 MDR-K.pneumoniae strains to 12 antibiotics according to the different sites of infections

Antimicrobial Pancreas (peri) (n = 53) Bloodstream (n = 32) Lung (n = 27) Biliary tract (n = 1) Total strains (n = 113)
Amoxicillin-clavulanate 53 (100) 32 (100) 26 (96.3) 1 (100) 112 (99)
Amikacin 28 (52.8) 18 (56.2) 17 (63) 0 (0) 63 (55.8)
Aztreonam 45 (84.9) 29 (90.6) 26 (96.3) 1 (100) 101 (89.4)
Ciprofloxacin 44 (83) 29 (90.6) 24 (88.9) 1 (100) 98 (86.7)
Gentamicin 39 (73.6) 26 (81.3) 25 (92.6) 0 (0) 90 (79.6)
Imipenem 38 (71.7) 26 (81.3) 24 (88.9) 1 (100) 89 (78.8)
Meropenem 38 (71.7) 26 (81.3) 23 (85.2) 1 (100) 88 (77.9)
Levofloxacin 42 (79.2) 29 (90.6) 25 (92.6) 1 (100) 97 (85.8)
Sulfamethoxazole 20 (37.7) 14 (43.8) 11 (40.7) 1 (100) 67 (59.3)
Piperacillin-tazobactam 41 (77.4) 29 (90.6) 24 (88.9) 1 (100) 95 (84.1)
Ceftriaxone 46 (86.8) 30 (93.8) 27 (100) 1 (100) 104 (92.0)
Tigecycline 15 (28.3) 7 (21.9) 5 (18.5) 0 (0) 27 (23.9)

Values are no. (%) of resistant strains, except as indicated